| Customization: | Available |
|---|---|
| Application: | Intravenous |
| Usage Mode: | Intravenous |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Name |
Common Name:Linezolid Dextrose Injection |
|---|---|
| Ingredient |
The active pharmaceutical ingredient is Linezolid |
| Description | Colorless to light brown, clear liquid. |
| Indications |
This product is used to treat the following infections caused by the specific microbial susceptible strains: Vancomycin-resistant Enterococcus faecium infections, Nosocomial pneumonia, Complicated skin and skin soft tissue infections, Uncomplicated skin and skin soft tissue infections , Community-acquired pneumonia and concomitant bacteremia. |
| Strength |
100ml:0.2 g linezolid, 4.57 g anhydrous dextrose |
| Dosage and Administration |
The recommended dosage administration of this product for treatment of infections is described in the instructions. |
){kind=link}